BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 26757209)

  • 1. Cardiovascular Comorbidities Relate More than Others with Disease Activity in Rheumatoid Arthritis.
    Crepaldi G; Scirè CA; Carrara G; Sakellariou G; Caporali R; Hmamouchi I; Dougados M; Montecucco C
    PLoS One; 2016; 11(1):e0146991. PubMed ID: 26757209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In wealthier countries, patients perceive worse impact of the disease although they have lower objectively assessed disease activity: results from the cross-sectional COMORA study.
    Putrik P; Ramiro S; Hifinger M; Keszei AP; Hmamouchi I; Dougados M; Gossec L; Boonen A
    Ann Rheum Dis; 2016 Apr; 75(4):715-20. PubMed ID: 26314921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Look beyond the disease activity score of 28 joints (DAS28): tender points influence the DAS28 in patients with rheumatoid arthritis.
    Ton E; Bakker MF; Verstappen SM; Ter Borg EJ; van Albada-Kuipers IA; Schenk Y; van der Veen MJ; Bijlsma JW; Jacobs JW;
    J Rheumatol; 2012 Jan; 39(1):22-7. PubMed ID: 22002014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated DAS28-ESR in patients with rheumatoid arthritis who have comorbid fibromyalgia is associated more with tender joint counts than with patient global assessment or swollen joint counts: implications for assessment of inflammatory activity.
    Kannayiram S; Schmukler J; Li T; Goodson N; Sridhar A; Pincus T
    Clin Exp Rheumatol; 2024 May; 42(5):1083-1090. PubMed ID: 38525998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discordance between the patient's and physician's global assessment in rheumatoid arthritis: Data from the REAL study-Brazil.
    Guimarães MFBR; Pinto MRDC; Resende GG; Machado CJ; Vargas-Santos AB; Amorim RBC; Gomides APM; Albuquerque CP; Bértolo MB; Júnior PL; Santos IA; Giorgi RDN; Saciloto NC; Radominski SC; Borghi FM; Bonfiglioli KR; Silva HCD; Sauma MFLDC; Sauma ML; Medeiros JB; Pereira IA; Castro GRW; Brenol CV; Xavier RM; Mota LMH; Castelar-Pinheiro GDR
    PLoS One; 2020; 15(3):e0230317. PubMed ID: 32168350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
    El Miedany Y; Youssef SS; El Gaafary M
    J Rheumatol; 2006 Mar; 33(3):490-7. PubMed ID: 16511918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity Impacts Swelling of Ankle and Foot Joints in Early Rheumatoid Arthritis Patients.
    Ranganath VK; Duffy EL; Garg VK; Woodworth T; Taylor M; Paulus HE; Altman RD; Elashoff DA
    J Clin Rheumatol; 2019 Apr; 25(3):e8-e11. PubMed ID: 29683839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of Patient's Global Assessment of Disease Activity and Physician's Global Assessment of Disease Activity in patients with rheumatoid arthritis: A post hoc analysis of overall and Japanese results from phase 3 clinical trials.
    Kaneko Y; Takeuchi T; Cai Z; Sato M; Awakura K; Gaich C; Zhu B; Guo J; Tanaka Y
    Mod Rheumatol; 2018 Nov; 28(6):960-967. PubMed ID: 29278339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine Assessment of Patient Index Data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practice.
    Boone NW; Sepriano A; van der Kuy PH; Janknegt R; Peeters R; Landewé RBM
    RMD Open; 2019; 5(2):e001050. PubMed ID: 31908842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting the discrepancy between patient and physician global assessment in early rheumatoid arthritis: The Ontario Best Practices Research Initiative.
    Akhavan PS; Movahedi M; Cesta A; Bombardier C;
    Clin Exp Rheumatol; 2023 Nov; 41(11):2249-2256. PubMed ID: 37382462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of an
    Lee SJ; Jeong JH; Lee CH; Ahn BC; Eun JS; Kim NR; Kang JW; Nam EJ; Kang YM
    Arthritis Rheumatol; 2019 Aug; 71(8):1232-1240. PubMed ID: 30771237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low body mass index is adversely associated with radiographic joint damage in Indian patients with early rheumatoid arthritis.
    Velpula UD; Agrawal S; Thomas J; Prabu VN; Rajasekhar L; Narsimulu G
    J Rheumatol; 2011 Mar; 38(3):434-8. PubMed ID: 21078713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA).
    Dougados M; Soubrier M; Antunez A; Balint P; Balsa A; Buch MH; Casado G; Detert J; El-Zorkany B; Emery P; Hajjaj-Hassouni N; Harigai M; Luo SF; Kurucz R; Maciel G; Mola EM; Montecucco CM; McInnes I; Radner H; Smolen JS; Song YW; Vonkeman HE; Winthrop K; Kay J
    Ann Rheum Dis; 2014 Jan; 73(1):62-8. PubMed ID: 24095940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up.
    Manivel VA; Mullazehi M; Padyukov L; Westerlind H; Klareskog L; Alfredsson L; Saevarsdottir S; Rönnelid J
    Ann Rheum Dis; 2017 Sep; 76(9):1529-1536. PubMed ID: 28336519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicentre observational study comparing patient reported outcomes to assess reliability of swollen and tender joint assessments and response to certolizumab treatment as compared to clinician assessments in rheumatoid arthritis.
    Inderjeeth CA; Inderjeeth AJ; Raymond WD
    Int J Rheum Dis; 2019 Jan; 22(1):73-80. PubMed ID: 30187688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease activity score 28 as an instrument to measure disease activity in patients with early rheumatoid arthritis.
    Mäkinen H; Kautiainen H; Hannonen P; Möttönen T; Korpela M; Leirisalo-Repo M; Luukkainen R; Puolakka K; Karjalainen A; Sokka T
    J Rheumatol; 2007 Oct; 34(10):1987-91. PubMed ID: 17611990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is fatigue an inflammatory variable in rheumatoid arthritis (RA)? Analyses of fatigue in RA, osteoarthritis, and fibromyalgia.
    Bergman MJ; Shahouri SH; Shaver TS; Anderson JD; Weidensaul DN; Busch RE; Wang S; Wolfe F
    J Rheumatol; 2009 Dec; 36(12):2788-94. PubMed ID: 19918042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis.
    Ranzolin A; Brenol JC; Bredemeier M; Guarienti J; Rizzatti M; Feldman D; Xavier RM
    Arthritis Rheum; 2009 Jun; 61(6):794-800. PubMed ID: 19479706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low body mass index in long standing rheumatoid arthritis: relation to RA disease activity and functional indices.
    Gamal SM; Alkemary AK; Abdo MA; El Dakrony AHM
    Reumatismo; 2018 Jul; 70(2):72-77. PubMed ID: 29976040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different Rating of Global Rheumatoid Arthritis Disease Activity in Rheumatoid Arthritis Patients With Multiple Morbidities.
    Radner H; Yoshida K; Tedeschi S; Studenic P; Frits M; Iannaccone C; Shadick NA; Weinblatt M; Aletaha D; Smolen JS; Solomon DH
    Arthritis Rheumatol; 2017 Apr; 69(4):720-727. PubMed ID: 27860467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.